Send to

Choose Destination
See comment in PubMed Commons below
Biologics. 2012;6:147-54. doi: 10.2147/BTT.S24155. Epub 2012 Jun 20.

Ovarian cancer: emerging molecular-targeted therapies.

Author information

Rockville, MD, USA.


With about 22,000 new cases estimated in 2012 in the US and 15,500 related deaths, ovarian cancer is a heterogeneous and aggressive disease. Even though most of patients are sensitive to chemotherapy treatment following surgery, recurring disease is almost always lethal, and only about 30% of the women affected will be cured. Thanks to a better understanding of the molecular mechanisms underlying ovarian cancer malignancy, new therapeutic options with molecular-targeted agents have become available. This review discusses the rationale behind molecular-targeted therapies and examines how newly identified molecular targets may enhance personalized therapies for ovarian cancer patients.


BRCA; PI3K/Akt; angiogenesis; metabolism; ovarian cancer

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Support Center